Calcineurin fine tunes the balance between proliferation and differentiation of Notch-responsive progenitors in the pancreatic ducts to enable beta cell regeneration in zebrafish.
We previously reported sustained calcineurin (Cn) activation in human lymphoid malignancies, and showed that Cn inhibitors have antileukemic effects in mouse models of T-ALL. It was unclear ...
You have full access to this article via your institution. Though activation of the calcineurin pathway can produce cardiac hypertrophy in transgenic mice 3, the results of our study indicate that ...
Hosted on MSN11mon
Treatments for Eczema
Topical calcineurin inhibitors are a class of medications used to treat eczema, particularly atopic dermatitis. They do not contain steroids, making them a preferred choice for certain situations, ...
A 40-year-old man presented to the emergency department with a 5-day history of fevers, sore throat, fatigue, subjective ...
Several studies have found that azelaic acid is effective in treating inflammation. 'Topical calcineurin inhibitors like tacrolimus ointment or pimecrolimus cream can be effective.' A calcineurin ...
About LUPKYNIS LUPKYNIS is a second generation calcineurin inhibitor (CNI) with a dual mechanism of action, acting as an immunosuppressant through inhibition of T-cell activation and cytokine ...
Panelists discuss how the current treatment landscape for chronic graft-versus-host disease includes a range of immunosuppressive approaches, from traditional corticosteroids and calcineurin ...
Verywell Health on MSN1y
How Age Affects Eczema
Eczema refers to a group of skin conditions that usually appear before age 5 and clear up by adulthood. But it can persist or ...
Topical calcineurin inhibitors can be useful treatments, in particular, when rosacea and seborrheic dermatitis overlap. Severe cases can be treated with oral antifungal agents or phototherapy.
'Perioral dermatitis is a rash characterised by red bumps and dry, flaky patches around the mouth,' says Granite. Dr Maryam ...
About LUPKYNIS LUPKYNIS is a second generation calcineurin inhibitor (CNI) with a dual mechanism of action, acting as an immunosuppressant through inhibition of T-cell activation and cytokine ...